ALPHA COGNITION SECURES ADDITIONAL U.S. PATENT FOR ZUNVEYL (BENZGALANTAMINE) IN THE TREATMENT OF MILD TO MODERATE ALZHEIMER’S DISEASE
Source text: ID:nBw5Qvjy1a
Further company coverage: ACOG.O
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.